FRANKFURT (Reuters) – Roche on Wednesday said that third-quarter sales gained a currency-adjusted 9% to 15.14 billion Swiss francs ($17.46 billion).
That surpassed an analysts’ consensus estimate of 14.9 billion francs, based on LSEG data.
($1 = 0.8671 Swiss francs)
(Reporting by Ludwig Burger, Editing by Rachel More)
